ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,431.60
-0.04%
US Tech 100
19,168.00
0.52%
Dow Jones
38,589.16
-0.15%
Brent Oil
82.275
0.00%
Bitcoin
66,120.61
0.17%
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV
  6. Waverley Pharma Inc (WAVE)

  7. Waverley Pharma Inc (WAVE) News

WAVE

Waverley Pharma (WAVE)

Waverley Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:TSXV:WAVE
DateTimeSourceHeadlineSymbolCompany
04/30/20248:08PMPR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
11/22/20235:00PMPR Newswire (Canada)Waverley Pharma Announces Changes to Board of DirectorsTSXV:WAVEWaverley Pharma Inc
08/02/20234:37PMPR Newswire (Canada)Waverley Pharma Business UpdateTSXV:WAVEWaverley Pharma Inc
03/20/20237:55AMPR Newswire (Canada)Waverley Pharma Provides Business UpdateTSXV:WAVEWaverley Pharma Inc
01/11/20237:55AMPR Newswire (Canada)Waverley Pharma Provides Update on its PARP-1 Inhibitor ProgramTSXV:WAVEWaverley Pharma Inc
08/05/20218:05AMPR Newswire (Canada)Waverley Pharma Announces $3,000,000 Credit FacilityTSXV:WAVEWaverley Pharma Inc
05/27/20218:05AMPR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Pemetrexed with NHS EnglandTSXV:WAVEWaverley Pharma Inc
01/18/20218:40AMPR Newswire (Canada)Waverley Pharma Announces Successful Tender Award for Capecitabine with NHS ScotlandTSXV:WAVEWaverley Pharma Inc
11/12/202012:04PMPR Newswire (Canada)Waverley Pharma Announces Tentative ANDA Approval for Pemetrexed in the United StatesTSXV:WAVEWaverley Pharma Inc
09/23/20208:20AMPR Newswire (Canada)Waverley Pharma Announces Listing on the Frankfurt Stock Exchange (FSE: 5GZ)TSXV:WAVEWaverley Pharma Inc
09/08/202010:13AMPR Newswire (Canada)Waverley Pharma Announces Signing of Term Sheet to Acquire Exclusive Rights to Market Six Generic Oncology Products in the Un...TSXV:WAVEWaverley Pharma Inc
08/25/20208:15AMPR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed in Spain and Bortezomib in ItalyTSXV:WAVEWaverley Pharma Inc
07/30/20208:25AMPR Newswire (Canada)Waverley Pharma Announces Grant of Market Authorization for Pemetrexed and Bortezomib in Multiple European CountriesTSXV:WAVEWaverley Pharma Inc
06/25/20208:15AMPR Newswire (Canada)Waverley Pharma Announces Collaboration with Dr. David E. Herbert and the University of Manitoba for the Development of a Syn...TSXV:WAVEWaverley Pharma Inc
04/28/20204:53PMPR Newswire (Canada)Waverley Pharma Announces Reliance on Relief from Filing Requirements for Annual Financial StatementsTSXV:WAVEWaverley Pharma Inc
02/03/20208:15AMPR Newswire (Canada)Waverley Pharma Announces Appointment of New President and CEOTSXV:WAVEWaverley Pharma Inc
01/08/20205:09PMPR Newswire (Canada)Waverley Pharma Announces Executive Leadership ChangesTSXV:WAVEWaverley Pharma Inc
12/17/20198:00AMPR Newswire (Canada)Waverley Pharma Announces Grant of Marketing Authorization in the United Kingdom for ErlotinibTSXV:WAVEWaverley Pharma Inc
03/11/20198:25AMPR Newswire (Canada)Waverley Pharma Provides Market Update and Fiscal 2018 Preliminary RevenueTSXV:WAVEWaverley Pharma Inc
12/18/20188:25AMPR Newswire (Canada)Waverley Pharma Announces Distribution Agreement and First Sale of Generic Oncology Products in the United KingdomTSXV:WAVEWaverley Pharma Inc
07/23/20188:35AMPR Newswire (Canada)Waverley Pharma Announces Resignation of CEO and Appointment of New CEOTSXV:WAVEWaverley Pharma Inc
06/27/20188:35AMPR Newswire (Canada)Waverley Pharma Announces Filing of Two Abbreviated New Drug Applications in the United StatesTSXV:WAVEWaverley Pharma Inc
06/25/20188:30AMPR Newswire (Canada)Waverley Pharma Announces Acquisition of two Generic Oncology Products Currently Marketed in the United KingdomTSXV:WAVEWaverley Pharma Inc
04/17/20188:30AMPR Newswire (Canada)Waverley Pharma Announces Filing of its Second Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
03/12/20189:00AMPR Newswire (Canada)Waverley Pharma Announces Filing of Marketing Authorization Application in Select European Union CountriesTSXV:WAVEWaverley Pharma Inc
10/27/201710:01AMPR Newswire (Canada)L'OCRCVM permet la reprise de la négociation - WAVE (anciennement BUFF.P)TSXV:WAVEWaverley Pharma Inc
10/27/20179:59AMPR Newswire (Canada)IIROC Trading Resumption - WAVE (Formerly BUFF.P)TSXV:WAVEWaverley Pharma Inc
 Showing the most relevant articles for your search:TSXV:WAVE

Your Recent History

LSE
AN36
Citi Fun 25
BIT
PRY
Prysmian
BIT
F12531
Vontobel Financial Produ...
EU
INPHI
Royal Philips Electronic...
NASDAQ
FSZKX
Fidelity Advisor Sustain...
BIT
P1M3B9
BNP Paribas Issuance
NASDAQ
SNCI
Sonic Innovations
LSE
62FG
Anz Bank 3.93%
BIT
P1SSW9
BNP Paribas Issuance
BOV
CPFO11
Units
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved